Real-Life Use of T-VEC in Melanoma Patients in Austria, Switzerland, and Germany
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Real-Life Use of Talimogene Laherparepvec (T-VEC) in Melanoma Patients in Centers in Austria, Switzerland and Germany
J Immunother Cancer 2021 Feb 01;9(2)e001701, JM Ressler, M Karasek, L Koch, R Silmbrod, J Mangana, S Latifyan, V Aedo-Lopez, H Kehrer, F Weihsengruber, P Koelblinger, C Posch, J Kofler, O Michielin, E Richtig, C Hafner, C HoellerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.